These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Drugs on the horizon. De Haen P N Y State J Med; 1972 Aug; 72(15):1969-73. PubMed ID: 4506215 [No Abstract] [Full Text] [Related]
3. Use of drugs related to the treatment of diabetes mellitus and other cardiovascular risk factors in the Spanish population. The Di@bet.es study. Rojo-Martínez G; Valdés S; Colomo N; Lucena MI; Gaztambide S; Gomis R; Casamitjana R; Carmena R; Catalá M; Martínez-Larrad MT; Serrano-Ríos M; Castaño L; Vendrell J; Girbés J; Franch J; Vázquez JA; Mora-Peces I; Urrutia I; Pascual-Manich G; Ortega E; Menéndez E; Delgado E; Bordiú E; Castell C; López-Alba A; Goday A; Calle A; Bosch-Comas A; Soriguer F Rev Esp Cardiol (Engl Ed); 2013 Nov; 66(11):854-63. PubMed ID: 24773992 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Implications of Hypoglycemia in Diabetes Mellitus. Connelly KA; Yan AT; Leiter LA; Bhatt DL; Verma S Circulation; 2015 Dec; 132(24):2345-50. PubMed ID: 26667098 [No Abstract] [Full Text] [Related]
5. Pharmacological management of cardiovascular conditions and diabetes in older adults with HIV infection. Gedela K; Vibhuti M; Pozniak A; Ward B; Boffito M HIV Med; 2014 May; 15(5):257-68. PubMed ID: 24351025 [TBL] [Abstract][Full Text] [Related]
6. Oral hypoglycaemic drugs and cardiovascular disease in maturity onset diabetes. Raheja BS Indian Heart J; 1979; 31(4):213-7. PubMed ID: 489037 [No Abstract] [Full Text] [Related]
7. Medical therapy for the patient with obesity. Bray GA; Ryan DH Circulation; 2012 Apr; 125(13):1695-703. PubMed ID: 22474312 [No Abstract] [Full Text] [Related]
9. Diseases and their remedies. De Haen P N Y State J Med; 1973 Sep; 73(17):2168-73. PubMed ID: 4517014 [No Abstract] [Full Text] [Related]
10. The association between co-morbidity and the use of antidiabetics or adjunctive cardiovascular medicines in Australian veterans with diabetes. Zhang Y; Vitry A; Caughey G; Roughead EE; Ryan P; Gilbert A; Shakib S; McDermott R Diabetes Res Clin Pract; 2011 Jan; 91(1):115-20. PubMed ID: 21067836 [TBL] [Abstract][Full Text] [Related]
11. [Anti-diabetic therapy and cardiovascular disease]. Mannucci E G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 2):3s-4. PubMed ID: 27030117 [No Abstract] [Full Text] [Related]
12. [Anti-diabetic therapy and cardiovascular risk]. Mannucci E G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):3S. PubMed ID: 25623544 [No Abstract] [Full Text] [Related]
13. [Management of the side effects of oral hypoglycemic agents in diabetes mellitus]. Ishii J; Suzuki M Nihon Rinsho; 1990 Dec; 48 Suppl():955-61. PubMed ID: 2086978 [No Abstract] [Full Text] [Related]
14. [Current aspects of the mechanism of action of calcium antagonists in patients with diabetes mellitus]. Kostiuk OP; Zubkova ST Fiziol Zh (1978); 1992; 38(3):106-11. PubMed ID: 1499754 [TBL] [Abstract][Full Text] [Related]
15. [Rehabilitation of oral hypoglycemic agents]. Biron P Union Med Can; 1975 Sep; 104(9):1421-4. PubMed ID: 1179546 [No Abstract] [Full Text] [Related]
17. New drugs and new treatments. Walker E Mod Healthc (Short Term Care); 1975 Jul; 4(1):70B,70D. PubMed ID: 239322 [No Abstract] [Full Text] [Related]
18. [Which anti-inflammatory and which analgesic agents should one select for diabetics?]. Vinceneux P; Lubetski D; Kahn MF Journ Annu Diabetol Hotel Dieu; 1978; ():281-93. PubMed ID: 651102 [No Abstract] [Full Text] [Related]
19. Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature. Wu JW; Boudreau DM; Park Y; Simonds NI; Freedman AN Expert Opin Drug Saf; 2014 Aug; 13(8):1071-99. PubMed ID: 24999107 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular safety and diabetes drug development. Drucker DJ; Goldfine AB Lancet; 2011 Mar; 377(9770):977-9. PubMed ID: 21316097 [No Abstract] [Full Text] [Related] [Next] [New Search]